• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Aprepitant against pruritus in patients with solid tumours.

作者信息

Vincenzi Bruno, Fratto Maria Elisabetta, Santini Daniele, Tonini Giuseppe

机构信息

Medical Oncology, University Campus Bio-Medico, Rome, 00128 Rome, Italy.

出版信息

Support Care Cancer. 2010 Sep;18(9):1229-30. doi: 10.1007/s00520-010-0895-9. Epub 2010 Jun 11.

DOI:10.1007/s00520-010-0895-9
PMID:20544226
Abstract
摘要

相似文献

1
Aprepitant against pruritus in patients with solid tumours.阿瑞匹坦用于实体瘤患者的止痒治疗。
Support Care Cancer. 2010 Sep;18(9):1229-30. doi: 10.1007/s00520-010-0895-9. Epub 2010 Jun 11.
2
Topical aprepitant in clinical and experimental pruritus.局部应用阿瑞匹坦治疗临床和实验性瘙痒症。
Arch Dermatol. 2012 Aug;148(8):957-9. doi: 10.1001/archdermatol.2012.1018.
3
Aprepitant as an antipruritic agent?阿瑞匹坦作为一种止痒剂？
N Engl J Med. 2009 Oct 1;361(14):1415-6. doi: 10.1056/NEJMc0906670.
4
[Aprepitant and pruritus--comment].[阿瑞匹坦与瘙痒——评论]
Klin Onkol. 2012;25(6):491-2.
5
More on aprepitant for erlotinib-induced pruritus.关于阿瑞匹坦治疗厄洛替尼引起的瘙痒的更多信息。
N Engl J Med. 2011 Feb 3;364(5):486-7. doi: 10.1056/NEJMc1013027.
6
Aprepitant: an oral NK1 antagonist for the prevention of nausea and vomiting induced by highly emetogenic chemotherapy.阿瑞匹坦：一种口服NK1拮抗剂，用于预防高致吐性化疗引起的恶心和呕吐。
Drugs Today (Barc). 2004 Oct;40(10):853-63. doi: 10.1358/dot.2004.40.10.863745.
7
Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy.以神经激肽受体 1 为靶点的阿瑞匹坦：一种新的止痒策略。
PLoS One. 2010 Jun 4;5(6):e10968. doi: 10.1371/journal.pone.0010968.
8
The ups and downs of novel antiemetic drugs, part 1: substance P, 5-HT, and the neuropharmacology of vomiting.新型止吐药物的起伏，第1部分：P物质、5-羟色胺与呕吐的神经药理学
J Clin Psychiatry. 2003 May;64(5):498-9. doi: 10.4088/jcp.v64n0501.
9
Aprepitant for erlotinib-induced pruritus.阿瑞匹坦用于治疗厄洛替尼引起的瘙痒。
N Engl J Med. 2010 Jul 22;363(4):397-8. doi: 10.1056/NEJMc1003937.
10
Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant.预防化疗引起的恶心和呕吐：关注阿瑞匹坦。
Expert Opin Drug Metab Toxicol. 2009 Dec;5(12):1607-14. doi: 10.1517/17425250903451675.

引用本文的文献

1
Neurokinin 1 Receptor Antagonists for Pruritus.神经激肽 1 受体拮抗剂治疗瘙痒。
Drugs. 2021 Apr;81(6):621-634. doi: 10.1007/s40265-021-01478-1. Epub 2021 Mar 6.
2
The Impact of Immunological Checkpoint Inhibitors and Targeted Therapy on Chronic Pruritus in Cancer Patients.免疫检查点抑制剂和靶向治疗对癌症患者慢性瘙痒的影响。
Biomedicines. 2020 Dec 22;9(1):2. doi: 10.3390/biomedicines9010002.
3
Emerging Therapeutic Options for Chronic Pruritus.慢性瘙痒的新兴治疗选择

本文引用的文献

1
Aprepitant as an antipruritic agent?阿瑞匹坦作为一种止痒剂？
N Engl J Med. 2009 Oct 1;361(14):1415-6. doi: 10.1056/NEJMc0906670.
2
Antiemetic control: toward a new standard of care for emetogenic chemotherapy.止吐控制：迈向致吐性化疗护理的新标准。
Expert Opin Pharmacother. 2009 Mar;10(4):629-44. doi: 10.1517/14656560902731894.
3
Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis.新型神经激肽-1拮抗剂作为治疗化疗引起呕吐的止吐药。
Am J Clin Dermatol. 2020 Oct;21(5):601-618. doi: 10.1007/s40257-020-00534-y.
4
Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial.神经激肽-1 拮抗剂奥那司坦治疗癌症患者表皮生长因子受体抑制剂相关瘙痒：一项随机、安慰剂对照的 II 期试验。
BMJ Open. 2020 Feb 6;10(2):e030114. doi: 10.1136/bmjopen-2019-030114.
5
NK-1 Receptor Antagonists and Pruritus: Review of Current Literature.NK-1受体拮抗剂与瘙痒：当前文献综述
Dermatol Ther (Heidelb). 2019 Sep;9(3):391-405. doi: 10.1007/s13555-019-0305-2. Epub 2019 Jun 12.
6
Need for Flexible Adjustment of the Treatment Schedule for Aprepitant Administration against Erlotinib-Induced Refractory Pruritus and Skin Rush.针对厄洛替尼引起的难治性瘙痒和皮疹，需要灵活调整阿瑞匹坦给药治疗方案。
Case Rep Oncol. 2019 Jan 21;12(1):84-90. doi: 10.1159/000493256. eCollection 2019 Jan-Apr.
7
Aprepitant for the Treatment of Chronic Refractory Pruritus.阿瑞匹坦治疗慢性难治性瘙痒症。
Biomed Res Int. 2017;2017:4790810. doi: 10.1155/2017/4790810. Epub 2017 Sep 19.
8
Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature.阿瑞匹坦治疗难治性皮肤T细胞淋巴瘤相关瘙痒：4例病例及文献综述
BMC Cancer. 2017 Mar 16;17(1):200. doi: 10.1186/s12885-017-3194-8.
9
[New treatment options for chronic pruritus].[慢性瘙痒的新治疗选择]
Hautarzt. 2016 Aug;67(8):627-34. doi: 10.1007/s00105-016-3828-9.
10
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?特应性皮炎中慢性瘙痒的介质：能否消除瘙痒？
Clin Rev Allergy Immunol. 2016 Dec;51(3):263-292. doi: 10.1007/s12016-015-8488-5.
Support Cancer Ther. 2006 Apr 1;3(3):140-2. doi: 10.3816/SCT.2006.n.011.
4
What lies beneath the surface of the itch in adults?成人瘙痒症状背后隐藏着什么？
Allergy Asthma Proc. 2007 Mar-Apr;28(2):153-62. doi: 10.2500/aap.2007.28.2942.
5
Roles of substance P and NK(1) receptor in the brainstem in the development of emesis.P物质和NK(1)受体在脑干中于呕吐发生过程中的作用。
J Pharmacol Sci. 2003 Feb;91(2):87-94. doi: 10.1254/jphs.91.87.